Alliance with Jointown comes in time for Covid-19 vaccine storage and distribution efforts
Kuehne+Nagel, a third-party logistics (3PL) provider, has struck a strategic partnership with Jointown, China’s largest non-state-owned pharma distribution company, to accelerate its footprint in pharma and healthcare logistics in China.
Over the past decade, Kuehne+Nagel has been focused on developing pharma and healthcare expertise. The partnership with Jointown provides access to the distributor’s fully GxP (good practice)-compliant, in-country storage and distribution network, enabling Kuehne+Nagel to comply with the highly-regulated Chinese pharma and healthcare sector.
With Covid-19 vaccines becoming widely approved for use, Jointown and Kuehne+Nagel will collaborate to manage vaccine distribution in a safe and timely manner, executives say, using their respective strengths in vaccine storage and distribution, both in China and other regions
The Jointown agreement comes only a few days after Kuehne+Nagel entered into a binding agreement to purchase Apex International Corporation, one of Asia’s leading freight forwarders, in its largest acquisition to date.
Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In
October 30th 2024In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications.